Product Information
FAMCICLOVIR 125 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2144 per EA under NDC 31722070630. Its NADAC has been published 574 times since Jul 8, 2015.
FDA first approved this application on Sep 10, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722070630
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMCICLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA202438FDA Approved
9/10/2014
TE Code
AB
On Market Since
9/10/2014
Pharmacological Classes
Price Statistics
The NADAC for FAMCICLOVIR 125 MG TABLET has been published 574 times since Jul 8, 2015, and over the history we have for it it has declined 74.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2144 per EA |
|---|---|
| All-time high | $0.8483 (Jul 15, 2015) |
| All-time low | $0.2092 (Nov 20, 2024) |
| 52-week high | $0.2812 |
| 52-week low | $0.2139 |
| Median price | $0.3081 |
| Average price | $0.3918 |
| Largest weekly change | +70.0% (Mar 23, 2016) |
| Weeks tracked | 574 |
| Tracking since | Jul 8, 2015 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famciclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FAMCICLOVIR 125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FAMCICLOVIR 125 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.2144 per EA (NDC 31722070630), effective Sep 30, 2026.
How has the price of FAMCICLOVIR 125 MG TABLET changed over time?
Over the history we have for it, the NADAC for FAMCICLOVIR 125 MG TABLET has declined 74.7%. It has been tracked across 574 weekly CMS publications since Jul 8, 2015.
What are the highest and lowest recorded NADAC prices for FAMCICLOVIR 125 MG TABLET?
Since Jul 8, 2015, the NADAC for FAMCICLOVIR 125 MG TABLET has ranged from a low of $0.2092 (Nov 20, 2024) to a high of $0.8483 (Jul 15, 2015), with a median of $0.3081 per EA.
Are there cheaper alternatives to FAMCICLOVIR 125 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FAMCICLOVIR 125 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FAMCICLOVIR 125 MG TABLET?
FAMCICLOVIR 125 MG TABLET (NDC 31722070630) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.